1. A PHASE 1/2 STUDY OF MT‐3724 TO EVALUATE SAFETY, PHARMACODYNAMICS AND EFFICACY OF MT‐3724 FOR THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA. (12th June 2019) Authors: Burnett, C.A.; Hamlin, P.; Dabovic, K.; Higgins, J.; Persky, D.O. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 566 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗